GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » Gross-Profit-to-Asset %

Integral Diagnostics (Integral Diagnostics) Gross-Profit-to-Asset % : 55.41% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Integral Diagnostics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Integral Diagnostics's annualized Gross Profit for the quarter that ended in Dec. 2023 was $294.3 Mil. Integral Diagnostics's average Total Assets over the quarter that ended in Dec. 2023 was $531.1 Mil. Therefore, Integral Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 55.41%.


Integral Diagnostics Gross-Profit-to-Asset % Historical Data

The historical data trend for Integral Diagnostics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics Gross-Profit-to-Asset % Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 84.73 58.32 56.29 45.41 50.52

Integral Diagnostics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.34 44.52 49.56 50.88 55.41

Competitive Comparison of Integral Diagnostics's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Integral Diagnostics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integral Diagnostics's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's Gross-Profit-to-Asset % falls into.



Integral Diagnostics Gross-Profit-to-Asset % Calculation

Integral Diagnostics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=281.248/( (550.257+563.095)/ 2 )
=281.248/556.676
=50.52 %

Integral Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=294.332/( (563.095+499.195)/ 2 )
=294.332/531.145
=55.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Integral Diagnostics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Integral Diagnostics (Integral Diagnostics) Business Description

Traded in Other Exchanges
Address
45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000
Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.

Integral Diagnostics (Integral Diagnostics) Headlines